Problems associated with iontophoretic studies in the caudate nucleus and substantia nigra

Concurrent chronic administration of a CCK(B) antagonist can decrease tolerance to the ataxic effects of ethanol.

Addiction biology·2010

Anatomic localization of dyskinesia in children with "profound" perinatal hypoxic-ischemic injury.

AJNR. American journal of neuroradiology·2009

Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.

Neuropharmacology·2005

Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society·2004

The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease.

Experimental neurology·2004

Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate.

Experimental neurology·2004

Targeted optical uncaging of an adenosine A1 receptor agonist regulates excitability of hippocampal slices derived from epileptic mice.

Neuropharmacology·2026

Role of the tail of the ventral tegmental area in the regulation of maternal behaviour: a pharmacological study in postpartum rats.

Neuropharmacology·2026

Dimethyl fumarate ameliorates behavioural and brain oscillatory alterations induced by prenatal valproic acid exposure in female rats.

Neuropharmacology·2026

Hippocampal teneurin-4 knockdown promotes depression-like behavioral phenotypes by disrupting oligodendrocyte differentiation in mice.

Neuropharmacology·2026

Dual MDM2 and PPARG regulatory axes mediate the antiepileptic effects of Gouteng: An integration of bioinformatics, network pharmacology, machine learning, molecular docking, and MD simulations.

Neuropharmacology·2026

The positive feedback interaction between mast cell-derived tryptase and NETs formation in the pathogenesis of sepsis-associated encephalopathy.

Neuropharmacology·2026

Candidate Right Locus Coeruleus-Centered Symptom Pathways in Young Major Depressive Disorder: A Multimodal Magnetic Resonance Imaging Study.

Human brain mapping·2026

Non-invasive brain stimulation to prevent aging-related diseases: What does photobiomodulation offer compared with other methods.

International review of neurobiology·2026

Connectome-based modeling of the suicidal brain: neurobiological substrates, clinical translation and future perspectives.

Biological psychiatry·2026

Neurocognitive outcomes in survivors of severe burn injuries: A systematic review.

Burns : journal of the International Society for Burn Injuries·2026

Magnetic control of nano-cerebrospinal fluid dynamics in the subarachnoid region: Neurotherapeutic applications.

Computational biology and chemistry·2026

Electrophysiological, neurocognitive, and GFAP biomarker responses to corticosteroid therapy in children with ESES/CSWS.

Applied neuropsychology. Child·2026

Related Experiment Videos

Problems associated with iontophoretic studies in the caudate nucleus and substantia nigra

Related Concept Videos

Concurrent chronic administration of a CCK(B) antagonist can decrease tolerance to the ataxic effects of ethanol.

Anatomic localization of dyskinesia in children with "profound" perinatal hypoxic-ischemic injury.

Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.

Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease.

The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease.

Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate.

Targeted optical uncaging of an adenosine A1 receptor agonist regulates excitability of hippocampal slices derived from epileptic mice.

Role of the tail of the ventral tegmental area in the regulation of maternal behaviour: a pharmacological study in postpartum rats.

Dimethyl fumarate ameliorates behavioural and brain oscillatory alterations induced by prenatal valproic acid exposure in female rats.

Hippocampal teneurin-4 knockdown promotes depression-like behavioral phenotypes by disrupting oligodendrocyte differentiation in mice.

Dual MDM2 and PPARG regulatory axes mediate the antiepileptic effects of Gouteng: An integration of bioinformatics, network pharmacology, machine learning, molecular docking, and MD simulations.

The positive feedback interaction between mast cell-derived tryptase and NETs formation in the pathogenesis of sepsis-associated encephalopathy.

Candidate Right Locus Coeruleus-Centered Symptom Pathways in Young Major Depressive Disorder: A Multimodal Magnetic Resonance Imaging Study.

Non-invasive brain stimulation to prevent aging-related diseases: What does photobiomodulation offer compared with other methods.

Connectome-based modeling of the suicidal brain: neurobiological substrates, clinical translation and future perspectives.

Neurocognitive outcomes in survivors of severe burn injuries: A systematic review.

Magnetic control of nano-cerebrospinal fluid dynamics in the subarachnoid region: Neurotherapeutic applications.

Electrophysiological, neurocognitive, and GFAP biomarker responses to corticosteroid therapy in children with ESES/CSWS.

Related Experiment Videos

Problems associated with iontophoretic studies in the caudate nucleus and substantia nigra

Related Concept Videos

Related Articles